(Q54576089)

1 June 2018

title

Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. (English)

1 reference

1 June 2018

1 reference

1 reference

3

Zhao-Qian Liu

1 reference

1 June 2018

Yong-Fang Hu

1

1 reference

1 June 2018

Wen Qiu

2

1 reference

1 June 2018

Li-Jun Zhu

4

1 reference

1 June 2018

Zhong-Qi Liu

5

1 reference

1 June 2018

Jiang-Hua Tu

6

1 reference

1 June 2018

Dan Wang

7

1 reference

1 June 2018

Zhi Li

8

1 reference

1 June 2018

Jun He

9

1 reference

1 June 2018

Gan-Ping Zhong

10

1 reference

1 June 2018

Gan Zhou

11

1 reference

1 June 2018

Hong-Hao Zhou

12

1 reference

1 June 2018

publication date

1 November 2006

1 reference

1 June 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

1 June 2018

volume

33

1 reference

1 June 2018

issue

11

1 reference

1 June 2018

page(s)

1093-1098

1 reference

1 June 2018

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

New concepts in cyclosporine monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Review: metabolism of immunosuppressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Cyclosporine pharmacokinetics and pharmacodynamics in African American and white subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

A general method for isolation of high molecular weight DNA from eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Sequencing: not always the "gold standard".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

CYP3A5 phenotype-genotype correlations in a British population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

A genetic test for immunosuppressant dose selection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04492.X

10.1111/J.1440-1681.2006.04492.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

release_7hfapengbbg4rbtdfihuvfnhia

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7hfapengbbg4rbtdfihuvfnhia

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17042920

1 reference

1 June 2018